Michael Hettich

1.3k total citations
15 papers, 668 citations indexed

About

Michael Hettich is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Hettich has authored 15 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Hettich's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Michael Hettich is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Michael Hettich collaborates with scholars based in Germany, Switzerland and United States. Michael Hettich's co-authors include Gabriele Niedermann, Shruthi Prasad, Friederike Braun, Mark Bartholomä, Reinhold Schirmbeck, Elke Firat, Simone Gaedicke, Xuekai Zhu, Volker Arolt and Walter Sibrowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Michael Hettich

14 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hettich Germany 8 400 196 141 113 103 15 668
Anuradha Krishnamurthy United States 12 245 0.6× 148 0.8× 119 0.8× 53 0.5× 54 0.5× 25 575
Brenda J. Gehrke United States 11 315 0.8× 137 0.7× 112 0.8× 17 0.2× 71 0.7× 17 821
P.M.L. Santos United States 15 265 0.7× 414 2.1× 26 0.2× 80 0.7× 27 0.3× 24 744
Vladimir A. Ljubimov United States 11 94 0.2× 62 0.3× 27 0.2× 96 0.8× 32 0.3× 20 781
Steve Lu United States 9 415 1.0× 176 0.9× 48 0.3× 13 0.1× 67 0.7× 23 885
S. Lindsey Davis United States 15 244 0.6× 71 0.4× 22 0.2× 21 0.2× 28 0.3× 52 831
Chun Shen China 7 255 0.6× 404 2.1× 14 0.1× 55 0.5× 9 0.1× 11 693
Shilong Sun China 16 66 0.2× 127 0.6× 122 0.9× 41 0.4× 16 0.2× 44 466
Lotte K. Kristensen Denmark 13 172 0.4× 107 0.5× 164 1.2× 10 0.1× 7 0.1× 22 463
Melis Yilmaz United States 6 242 0.6× 119 0.6× 23 0.2× 49 0.4× 10 0.1× 13 541

Countries citing papers authored by Michael Hettich

Since Specialization
Citations

This map shows the geographic impact of Michael Hettich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hettich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hettich more than expected).

Fields of papers citing papers by Michael Hettich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hettich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hettich. The network helps show where Michael Hettich may publish in the future.

Co-authorship network of co-authors of Michael Hettich

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hettich. A scholar is included among the top collaborators of Michael Hettich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hettich. Michael Hettich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Caudell, David L., et al.. (2021). 11 Molecular characterization of naturally occurring colorectal and breast cancer in non-human primates to model human immunotherapeutic agents. SHILAP Revista de lepidopterología. A11–A11. 1 indexed citations
2.
García‐Velloso, María José, Iván Peñuelas, Mariano Ponz‐Sarvisé, et al.. (2020). 286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer. Regular and Young Investigator Award Abstracts. A175.1–A175. 4 indexed citations
3.
Ceppi, Maurizio, Michael Hettich, Volker Teichgräber, et al.. (2020). Abstract 6135: Tumor-bearing non-human primates: An unrivaled model for translational cancer immunology research. Cancer Research. 80(16_Supplement). 6135–6135. 4 indexed citations
4.
Hua, Jing, Michael Hettich, Simone Gaedicke, et al.. (2019). Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation. Journal for ImmunoTherapy of Cancer. 7(1). 55–55. 17 indexed citations
5.
Eckert, Franziska, Udo S. Gaipl, Gabriele Niedermann, et al.. (2017). Beyond checkpoint inhibition – Immunotherapeutical strategies in combination with radiation. Clinical and Translational Radiation Oncology. 2. 29–35. 28 indexed citations
6.
Hettich, Michael, et al.. (2016). Checkpoint Antibodies but not T Cell–Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation. Cancer Research. 76(16). 4673–4683. 59 indexed citations
7.
Hettich, Michael, Friederike Braun, Mark Bartholomä, Reinhold Schirmbeck, & Gabriele Niedermann. (2016). High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers. Theranostics. 6(10). 1629–1640. 161 indexed citations
8.
Hettich, Michael, Friederike Braun, & Gabriele Niedermann. (2016). Positron Emission Tomography Imaging of the PD-1/PD-L1 Checkpoint in Naïve and Irradiated Tumor-Bearing Mice. International Journal of Radiation Oncology*Biology*Physics. 96(2). S128–S129. 1 indexed citations
9.
Prasad, Shruthi, Simone Gaedicke, Márcia Regina Machein, et al.. (2015). Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell–Engaging Antibody and CD8 T Cells. Cancer Research. 75(11). 2166–2176. 28 indexed citations
10.
Gaedicke, Simone, Friederike Braun, Shruthi Prasad, et al.. (2014). Noninvasive positron emission tomography and fluorescence imaging of CD133 + tumor stem cells. Proceedings of the National Academy of Sciences. 111(6). E692–701. 82 indexed citations
11.
Zhu, Xuekai, Shruthi Prasad, Simone Gaedicke, et al.. (2014). Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57. Oncotarget. 6(1). 171–184. 128 indexed citations
12.
Hettich, Michael. (2014). The Windows. 40(4). 91–91.
13.
Freude, S, Katharina Schilbach, Michael Hettich, et al.. (2011). Neuron-specific Deletion of a Single Copy of the Insulin-like Growth Factor-1 Receptor Gene Reduces Fat Accumulation during Aging. Hormone and Metabolic Research. 44(2). 99–104. 7 indexed citations
14.
Kaestner, Florian, Michael Hettich, Marion Peters, et al.. (2005). Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. Journal of Affective Disorders. 87(2-3). 305–311. 145 indexed citations
15.
Lamm, Kerstin, et al.. (1990). [Effect and effectiveness of hyperbaric oxygen therapy in chronic hearing disorders. Report of 557 cases 1989].. PubMed. 38(11). 408–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026